Guerrero-Miranda Cesar Y, Hall Shelley A
Annette C. and Harold C. Simmons Transplant Institute, Baylor Scott & White Research Institute, Dallas, TX, USA.
Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, TX, USA.
Ann Cardiothorac Surg. 2019 Jan;8(1):123-128. doi: 10.21037/acs.2018.11.08.
Extracorporeal membrane oxygenation (ECMO) is used to support critically ill patients when conventional therapies have failed. ECMO has been available for four decades and has gained use as a rescue therapy in severe refractory hypoxic disorders and in patients with refractory cardiogenic shock (RCS). Over recent years, several percutaneous cardiac interventions and implant devices have been developed that are now used frequently in conjunction with ECMO in order to maintain organ perfusion. Here, we review the literature on VA-ECMO cannulation location, the use of VA-ECMO in interventions (e.g., coronary interventions and structural heart interventions) and percutaneous cardiac device implantation in VA-ECMO recipients with RCS.
当传统疗法无效时,体外膜肺氧合(ECMO)用于支持重症患者。ECMO已经应用了40年,并且已成为严重难治性低氧血症和难治性心源性休克(RCS)患者的一种挽救疗法。近年来,已经开发出几种经皮心脏介入治疗和植入装置,现在它们经常与ECMO联合使用,以维持器官灌注。在此,我们综述了关于VA-ECMO插管位置、VA-ECMO在介入治疗(如冠状动脉介入治疗和结构性心脏病介入治疗)中的应用以及在患有RCS的VA-ECMO接受者中经皮心脏装置植入的文献。